Matthew Sayer
Adult Health · Savannah, GANPI 1710650155
Payments from drug & device makers
Across 33 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$71
- Novartis$56
- Amgen$49
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$49
- AbbVie$42
- Currax Pharmaceuticals LLC$41
- plus $230 from 12 others
What the payments were for
- Food & beverage$538100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 5 | $71 |
| Novartis | 4 | $56 |
| Amgen | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| AbbVie | 2 | $42 |
| Currax Pharmaceuticals LLC | 3 | $41 |
| Vericel Corporation | 1 | $29 |
| Boston Scientific | 1 | $24 |
| Mannkind Corporation | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 2 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Merck | 1 | $17 |
| Pfizer | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
| GSK | 1 | $12 |
How this compares
$538 in reported general payments places this provider in the 55th percentile of 577 adult health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 16 | $1,076 |
| Cephalexin | 11 | $129 |
| Promethazine Hcl | 19 | $90 |
| Meloxicam | 35 | $58 |
Paid to pharmacies, not to this prescriber.
Other adult health in Savannah
- Amanda MerrittSavannah$16K
- Karen MosesSavannah$11K
- Jennie VandenhoutenSavannah$10K
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.